Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proviera is a private industrial biotechnology company that develops probiotic-derived biochemicals for leather processing rather than human therapeutics. The company markets natural, non-toxic alternatives to conventional petroleum-based tanning chemicals, with products spanning hide soaking, wetting/dispersing, and degreasing applications. Proviera operates as an affiliate of SCD Probiotics and builds its products on SCD's proprietary consortia technology and mother culture platform. Its offerings are positioned around sustainability, reduced waste, lower water and chemical use, and improved leather-processing economics for tanneries. The company appears to be commercial-stage, with marketed products including ProSoak, ProSpread, and ProDegreaze and licensing activity in international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proviera Biotech.